Novo Nordisk A/S
NVO
$47.26
$1.292.81%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.14% | 25.03% | 5.48% | 10.95% | 24.06% |
| Total Depreciation and Amortization | 22.66% | 47.82% | 73.63% | 90.31% | 58.14% |
| Total Amortization of Deferred Charges | 36.01% | 36.01% | 36.01% | 18.52% | 18.52% |
| Total Other Non-Cash Items | 32.02% | -133.76% | -155.09% | -75.20% | -65.72% |
| Change in Net Operating Assets | 1.74% | -220.00% | 365.33% | 106.28% | -511.59% |
| Cash from Operations | 13.71% | -2.80% | 3.76% | 9.36% | 7.95% |
| Capital Expenditure | -5.72% | -19.80% | -33.66% | -45.36% | -65.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -196.95% | -- |
| Cash Acquisitions | 101.34% | 101.33% | 101.33% | -11,983.50% | -11,983.50% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -675.32% | -488.21% | -7,330.47% | 207.79% | 152.66% |
| Cash from Investing | 32.82% | 34.66% | 34.81% | -142.03% | -195.15% |
| Total Debt Issued | -43.75% | -13.31% | 30.91% | 240.93% | 240.38% |
| Total Debt Repaid | 61.92% | -278.88% | -1,150.01% | -1,154.08% | -1,200.60% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 47.72% | 87.19% | 93.12% | 60.45% | 56.91% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.45% | -10.45% | -17.53% | -17.53% | -18.84% |
| Other Financing Activities | -41.34% | -208.47% | -- | -- | -- |
| Cash from Financing | 7.85% | -241.93% | -514.48% | 29.28% | 30.96% |
| Foreign Exchange rate Adjustments | 90.44% | -408.53% | -271.16% | 66.65% | -294.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 178.21% | -156.93% | 491.38% | -192.12% | -213.65% |